This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Society for Research on Nicotine and Tobacco | |
|---|---|
| Name | Society for Research on Nicotine and Tobacco |
| Abbreviation | SRNT |
| Formation | 1994 |
| Type | Learned society |
| Headquarters | United States |
| Region served | International |
| Leader title | President |
Society for Research on Nicotine and Tobacco is an international learned society devoted to the scientific study of nicotine, tobacco, and nicotine delivery systems with links to public health, regulatory science, and clinical practice. The organization engages researchers, clinicians, and policymakers from institutions such as National Institutes of Health, World Health Organization, Centers for Disease Control and Prevention, Food and Drug Administration, and European Commission to advance evidence-based approaches. It interacts with stakeholders including American Public Health Association, Royal College of Physicians, Johns Hopkins University, University of California, San Francisco, and University College London to translate research into policy and practice.
The society was founded amid discussions involving figures from Royal College of Physicians, Centers for Disease Control and Prevention, National Cancer Institute, Johns Hopkins Bloomberg School of Public Health, and the World Health Organization during the early 1990s tobacco control movement. Early conferences attracted contributors affiliated with Harvard University, Brown University, Yale University, University of California, San Diego, and Massachusetts General Hospital, reflecting cross-institutional research on nicotine dependence, cessation, and harm reduction. Over time leadership included investigators connected to University of Pennsylvania, Columbia University, University of Toronto, McGill University, and University of Sydney, shaping work on regulation, behavior, and toxicology. The society’s evolution paralleled regulatory milestones at the Food and Drug Administration, public health campaigns by the Centers for Disease Control and Prevention, litigation involving Philip Morris International, and global treaties such as the WHO Framework Convention on Tobacco Control.
The society’s mission emphasizes rigorous research linking basic science, clinical trials, epidemiology, and policy, engaging partners like National Institutes of Health, European Medicines Agency, Public Health England, Canadian Cancer Society, and Campaign for Tobacco-Free Kids. Objectives include promoting interdisciplinary collaboration among investigators from Brown University, Duke University, University of Michigan, University of Oslo, and Monash University to reduce tobacco-related morbidity, inform regulators at the Food and Drug Administration and European Commission, and support evidence used by courts such as in cases involving R.J. Reynolds Tobacco Company and British American Tobacco. The society prioritizes training through ties with academic centers including Stanford University, University of Pittsburgh, University of Glasgow, King's College London, and Imperial College London.
Membership draws researchers, clinicians, and trainees from institutions like Johns Hopkins University, Yale University School of Medicine, University of California, Los Angeles, University of Toronto, and University of Edinburgh. Governance is overseen by an elected board with officers who have affiliations spanning National Institutes of Health, American Thoracic Society, Addiction Journal editorial board, Royal Society of Medicine, and Society for Epidemiologic Research. Committees coordinate activities related to ethics, finance, and scientific programs, often collaborating with organizations such as Society for Academic Emergency Medicine, International Society for Pharmacoeconomics and Outcomes Research, European Respiratory Society, and American Association for Cancer Research.
Annual meetings convene investigators from National Cancer Institute, Centers for Disease Control and Prevention, Food and Drug Administration, Harvard School of Public Health, and University College London to present basic science, clinical trials, and policy analyses. Regional and satellite symposia partner with bodies like European Respiratory Society, Association for the Treatment of Tobacco Use and Dependence, International Society for Research on Nicotine and Tobacco, and national academies including Academy of Medical Sciences and Royal Society. plenary sessions have featured speakers from World Health Organization, National Institutes of Health, U.S. Surgeon General, British Medical Journal, and The Lancet on topics linking toxicology, behavioral science, and regulation. Workshops and training sessions are often co-sponsored by American Public Health Association, Society for Prevention Research, International Society of Addiction Journal Editors, and academic centers such as Johns Hopkins Bloomberg School of Public Health.
The society supports peer-reviewed dissemination through journals and special issues involving editors from Addiction Journal, Tobacco Control, Nicotine & Tobacco Research editorial board, American Journal of Public Health, and The Lancet Respiratory Medicine. Members publish empirical studies with collaborators at National Institutes of Health, National Cancer Institute, University of California, San Francisco, Harvard Medical School, and University of Toronto. Position statements and consensus reports inform stakeholders including World Health Organization, Food and Drug Administration, European Commission, Public Health England, and Canadian Public Health Association. The society’s outputs are cited in guidelines by National Institute for Health and Care Excellence, policy briefs by Campaign for Tobacco-Free Kids, and analyses in BMJ and New England Journal of Medicine.
Research promoted by the society has influenced regulatory actions at the Food and Drug Administration, international guidance from the World Health Organization, litigation involving Philip Morris International and British American Tobacco, and public health recommendations from Centers for Disease Control and Prevention and National Cancer Institute. Areas of impact include nicotine dependence treatment protocols used in clinics at Massachusetts General Hospital, harm reduction debates involving electronic cigarette manufacturers, youth prevention programs supported by Truth Initiative, and surveillance data informing Global Tobacco Surveillance System. Collaborative research networks include investigators from University College London, University of Sydney, University of Toronto, McGill University, and Seoul National University.
The society administers awards and grants to researchers, trainees, and clinicians, frequently recognizing work associated with National Institutes of Health funding, career awards linked to National Cancer Institute, and fellowships coordinated with Centers for Disease Control and Prevention training programs. Prize lectures and honors have been awarded to investigators from Harvard University, Johns Hopkins University, University of California, San Francisco, King's College London, and University of Toronto. Grant programs support early-career researchers collaborating with institutions such as Duke University, Yale University, University of Michigan, Monash University, and Imperial College London to advance tobacco control, cessation science, and regulatory research.
Category:Medical societies